Calamos Advisors
AGN

Calamos Advisors’s Allergan plc AGN Stock Holding History

Calamos Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,800
Closed -$3.78M – 802
2019
Q1 		$3.78M Buy
+25,800
New +$3.74M 0.02% 498

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Calamos Advisors's AGN Position: Q2 2020 in Review

Calamos Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 378,418 shares — an estimated $67M sold.

Calamos Advisors first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $128M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Calamos Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Calamos Advisors sold 378,418 Allergan plc shares in Q2 2020, an estimated $67M.
  • Calamos Advisors first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
  • Calamos Advisors's Allergan plc position peaked at $128M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.